S&P 500 Gains as Big Tech Stocks Deliver Mixed Returns
The direction the S&P 500 (Index: SPX) takes is shaping up a lot like a playing a game that has a 50% chance of winning or a 50% chance of losing.
Investors saw that game play out during the past week as several of the Big Tech companies that dominate the index reported their earnings and updated their outlooks. For example, the world’s biggest company, Apple (NASDAQ: AAPL) briefly touched a $5 trillion valuation before disappointing investors with its supply chain struggles, sending its shares lower.
But that loss was offset for the index as both Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) were more positive.
By the time the trading week ended on Friday, 31 July 2026, the bulls came out ahead as the index rose almost 1.1% above its previous week’s close to reach a value of 7,489.72.
The latest update of the alternative futures chart shows stock prices are consistent with investors focusing their forward looking attention on either the current quarter of 2026-Q3 or the more distant quarter of 2026-Q4.
The dividend futures-based model indicates very little difference in where it projects the level of the S&P 500 would be for investors fixing their attention on either these two future quarters.
As for why these two quarters would be of particular interest to investors, they happen to represent the likely timing of when the Fed will act to change the Federal Funds Rate. The CME Group’s FedWatch Tool projects two quarter point rate hikes before the end of 2026. The first would occur after the Fed meets on 16 September (2026-Q3) and the second would take place on 9 December (2026-Q4).
Here are the market-moving headlines of the week that was:
- Monday, 27 July 2026
-
- Signs and portents for the U.S. economy:
- US core capital goods orders rise, shipments post largest gain in 4-1/2 years amid AI investment boom
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- Bigger trouble, stimulus developing in China:
- China’s industrial profit growth moderates as exports cushion uneven recovery
- China begins making homegrown DUV chipmaking tools, The Information reports
- China accuses US of ‘AI hegemonism’, threatens countermeasures over potential probes
- China opposes US ‘forced labour’ tariffs, calls for them to be cancelled
- BOJ minions getting excited to hike Japan’s interest rates some more:
- ECB minions say interest rate hikes will continue until Eurozone morale improves:
- ECB’s Kazimir: September rate hike likely needed even if outlook improves
- ECB facing mid-sized inflation shock, will get to 2% in year or so, Lane says
- Wall Street closed mixed as eyes remained focused on U.S.-Iran relations
- Tuesday, 28 July 2026
-
- Signs and portents for the U.S. economy:
- US goods trade deficit shrinks, is still expected to weigh on Q2 GDP growth
- Oil prices fall 5% to two-week low after several days without US-Iran strikes
- Fed minions not expected to hike U.S. interest rates this week:
- Uneven economic growth developing in China:
- Bigger trouble developing everywhere:
- S&P 500 ends higher as investors await tech earnings
- Wednesday, 29 July 2026
-
- Signs and portents for the U.S. economy:
- US mortgage rates climb again in latest week, many at year high
- Oil jumps 7% on escalating Middle East airstrikes
- OpenAI’s rogue agent compromised a customer at a second tech firm
- Fed minions follow through on expectations with no rate hike, three minions dissented:
- VIEW Fed holds rates steady as three policymakers dissent for a hike
- No Rate-Change Sparks 3 Dissents As Warsh Fed Delivers Biggest ‘Non-Cut’ Surprise In Decades
- Fed meeting recap: Warsh says Fed won’t hesitate to stop inflation, but bond market has doubts
- Bigger stimulus developing in China:
- Wall Street ends lower as FOMC holds interest rates steady
- Thursday, 30 July 2026
-
- Signs and portents for the U.S. economy:
- US economic growth slows but domestic demand robust
- Oil edges down in choppy trading amid Oman-Iran talks, US-Iran tensions
- Fed minions see long-term interest rates rise after sending “muddled” message:
- Bigger trouble, smaller stimulus developing in China:
- China’s leaders pledge to support economy without big new stimulus plans
- BOJ minions suspected of taking action to prop up Japan’s currency:
- Faster growth, bigger inflation developing in Eurozone:
- Euro zone economy grows faster than expected on AI spending, confident consumers
- German inflation accelerates to 2.8% in July
- Wall Street closed higher as chips rallied and latest GDP and inflation figures landed
- Friday, 31 July 2026
-
- Signs and portents for the U.S. economy:
- Oil falls more than $1 on greater flows despite US-Iran war
- US Treasury yield curve ‘twist’ reflects view Fed may not hike again
- Fed minions make case for September rate hike, some argue inflation is lowest it’s been in years, chief Fed minion thinking about changing the schedule:
- Fed dissenters sketch the case for a rate hike
- As Warsh’s Fed faces pressure to act on inflation, these indicators show it’s at its lowest in years
- Warsh raised changing frequency of Fed policy meetings, NYT reports
- Bigger trouble, stimulus developing in China:
- China’s factory activity shrinks in July as demand falters, fuelling slowdown concerns
- China approves eight new nuclear power units
- BOJ minions pass on hiking Japan’s interest rates, but hint they’ll resume hiking them later with inflation rising; also busy with propping up Japan’s currency:
- Annual core inflation in Japan’s capital accelerates in July
- BOJ nods to chance of early rate hike as Tokyo props up yen
- Japan intervenes to prop up yen ahead of BOJ policy decision, source says
- Japan may have sold up to $59 billion in yen-buying intervention
- History of Japan’s intervention in currency markets
- US Treasury informed banks that it may intervene in Japan’s yen, source says
- ECB minions see higher inflation in Eurozone:
- S&P 500 posts weekly gain as consumer discretionary shines
- Apple disappoints with forecast dogged by supply chain struggles
The BEA’s first estimate of annualized real GDP growth during 2026-Q2 is 1.5%, just a bit below the Atlanta Fed’s GDPNow tool‘s final estimate of +1.7% for the quarter. Meanwhile, GDPNow tool’s first estimate of real GDP growth for the U.S. economy in the now current quarter of 2026-Q3 is +5.0%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon showing a Wall Street bull and bear spinning a Price Is Right style Big Wheel labeled ‘WHICH WAY WILL STOCKS GO?’ with values ‘UP’ and ‘DOWN’”.
Source: https://politicalcalculations.blogspot.com/2026/08/s-500-gains-as-big-tech-stocks-deliver.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



